Polymeric nanoparticles in development for treatment of pulmonary infectious diseases

Keyphrases

• Polymeric Nanoparticles 100%
• Respiratory Infectious Diseases 100%
• Antimicrobial 50%
• Pulmonary Infection 50%
• Lung 25%
• Pneumonia 25%
• Life-threatening 25%
• Tuberculosis 25%
• Nanoparticles 25%
• Biodistribution 25%
• Cystic Fibrosis 25%
• Therapeutic Agents 25%
• Cellular Barriers 25%
• Therapeutic Efficacy 25%
• Mode of Delivery 25%
• Infection Site 25%
• Delivery Vehicle 25%
• Efficient Delivery 25%
• Difficult-to-treat 25%
• Rational Design 25%
• Mucosal Barrier 25%
• Nanostructures 25%
• Shape Composition 25%
• Nanotechnology 25%
• Composition Characteristics 25%
• Direct Delivery 25%
• Lung Infection 25%
• Surface Characteristics 25%
• Systemic Exposure 25%
• Size Characteristics 25%
• Adverse Conditions 25%
• Improved Pharmacokinetics 25%
• Bacterial Disease 25%
• Therapeutic Toxicity 25%
• Lung Microenvironment 25%
• Therapeutic Efficiency 25%
• Drug-resistant Bacteria 25%
• Chronic Obstructive 25%
• Shape Characteristics 25%
• Multifunctional Nanodevices 25%
• Smart Features 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• Diseases 100%
• Lung Infection 60%
• Infection 20%
• Combination Therapy 20%
• Cystic Fibrosis 20%
• Biodistribution 20%
• Antiinfective Agent 20%
• Pharmacokinetics 20%
• Nanomaterial 20%